Arsenic contamination of water supplies may have played a significant role in the development of widespread resistance in the India to an important drug used to treat leishmaniasis, they say.
Visceral leishmaniasis infects around half a million people across the world every year and close to one-in-ten of those die, a release by the University of Dundee and Aberdeen said today.
One of the main treatments for the disease is a group of drugs known as antimonial preparations.
Now researchers at the Universities of Dundee and Aberdeen have concluded that arsenic contamination of the water supply may have played a significant role in building resistance to the drugs.
"The Indian subcontinent is the only region where arsenic contamination of drinking water coexists with widespread resistance to antimonial drugs which are used to treat visceral leishmaniasis," said Professor Alan Fairlamb, of the University of Dundee.
"This is important as we need to be sure of why resistance to drugs develops," he added.
Leishmaniasis is a neglected disease that has a devastating effect across the developing world and there is a desperate need for better drugs to treat it.
Meghan Perry, a Wellcome Trust-funded clinical PhD student working on the project, has also carried out field research in Bihar.
Knowledge of the dangers of arsenic pollution is low and mitigation projects are not reaching all of those in need.
The research is published in a paper in the journal PNAS (Proceedings of the National Academy of Sciences of the United States of America).
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
